To date, Biovista has profiled and screened 8 drugs with significant potential in Macular Degeneration, Glaucoma and Diabetic Retinopathy.

The company is currently in the process of filing for novel use patents for these drugs.

These drugs can be used either singly or in combination with other drugs, and we believe have significant promise in these hard to treat conditions.

To find out more about our program in eye disorders please contact us.